-
1
-
-
0025193635
-
Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene
-
Raycroft L, Wu H, Lozano G: Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051, 1990
-
(1990)
Science
, vol.249
, pp. 1049-1051
-
-
Raycroft, L.1
Wu, H.2
Lozano, G.3
-
2
-
-
0026770424
-
Wild-type p53 activates transcription in vitro
-
Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C: Wild-type p53 activates transcription in vitro. Nature 358:83-86, 1992
-
(1992)
Nature
, vol.358
, pp. 83-86
-
-
Farmer, G.1
Bargonetti, J.2
Zhu, H.3
Friedman, P.4
Prywes, R.5
Prives, C.6
-
3
-
-
0025815451
-
Identification of p53 as a sequence-specific DNA-binding protein
-
Kern S, Kinzler K, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B: Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708-1711, 1991
-
(1991)
Science
, vol.252
, pp. 1708-1711
-
-
Kern, S.1
Kinzler, K.2
Bruskin, A.3
Jarosz, D.4
Friedman, P.5
Prives, C.6
Vogelstein, B.7
-
4
-
-
0026702212
-
Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element
-
Zambetti G, Bargonetti J, Walker K, Prives C, Levine A: Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes & Dev 6:1143-1152, 1992
-
(1992)
Genes & Dev
, vol.6
, pp. 1143-1152
-
-
Zambetti, G.1
Bargonetti, J.2
Walker, K.3
Prives, C.4
Levine, A.5
-
5
-
-
0027244853
-
The p53mdm-2 autoregulatory feedback loop
-
Wu X, Bayle JH, Olson D, Levine AJ: The p53mdm-2 autoregulatory feedback loop. Genes & Dev 7:1126-1132, 1993
-
(1993)
Genes & Dev
, vol.7
, pp. 1126-1132
-
-
Wu, X.1
Bayle, J.H.2
Olson, D.3
Levine, A.J.4
-
6
-
-
0027359827
-
WAF1, a potential mediator of p53 tumor suppression
-
El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J, Lin D, Mercer W, Kinzler K, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993
-
(1993)
Cell
, vol.75
, pp. 817-825
-
-
El-Deiry, W.1
Tokino, T.2
Velculescu, V.3
Levy, D.4
Parsons, R.5
Trent, J.6
Lin, D.7
Mercer, W.8
Kinzler, K.9
Vogelstein, B.10
-
7
-
-
0027318117
-
Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53
-
Mack D, Vartikar J, Pipas J, Laimins L: Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363:281-283, 1993
-
(1993)
Nature
, vol.363
, pp. 281-283
-
-
Mack, D.1
Vartikar, J.2
Pipas, J.3
Laimins, L.4
-
9
-
-
0029028158
-
A direct effect of activated human p53 on nuclear DNA replication
-
Cox LS, Hupp T, Midgley CA, Lane DP: A direct effect of activated human p53 on nuclear DNA replication. EMBO J 14:2099-2105, 1995
-
(1995)
EMBO J
, vol.14
, pp. 2099-2105
-
-
Cox, L.S.1
Hupp, T.2
Midgley, C.A.3
Lane, D.P.4
-
10
-
-
0027358857
-
Inhibition of DNA replication factor RPA by p53
-
Dutta A, Ruppert J, Aster J, Winchester E: Inhibition of DNA replication factor RPA by p53. Nature 365:79-82, 1993
-
(1993)
Nature
, vol.365
, pp. 79-82
-
-
Dutta, A.1
Ruppert, J.2
Aster, J.3
Winchester, E.4
-
12
-
-
0031310665
-
14-3-3σi is a p53-regulated inhibitor of G2/M progression
-
Hermeking H, Lengauer C, Polyak K, He T, Zhang L, Thiagalingam S, Kinzler K, Vogelstein B: 14-3-3σi is a p53-regulated inhibitor of G2/M progression. Mol Cell 1:3-11, 1997
-
(1997)
Mol Cell
, vol.1
, pp. 3-11
-
-
Hermeking, H.1
Lengauer, C.2
Polyak, K.3
He, T.4
Zhang, L.5
Thiagalingam, S.6
Kinzler, K.7
Vogelstein, B.8
-
13
-
-
0025784539
-
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
-
Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347, 1991
-
(1991)
Nature
, vol.352
, pp. 345-347
-
-
Yonish-Rouach, E.1
Resnitzky, D.2
Lotem, J.3
Sachs, L.4
Kimchi, A.5
Oren, M.6
-
14
-
-
0027258466
-
Thymocyte apoptosis induced by p53-dependent and independent pathways
-
Clarke A, Purdie C, Harrison D, Morris R, Bird C, Hooper M, Wyllie A: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852, 1993
-
(1993)
Nature
, vol.362
, pp. 849-852
-
-
Clarke, A.1
Purdie, C.2
Harrison, D.3
Morris, R.4
Bird, C.5
Hooper, M.6
Wyllie, A.7
-
15
-
-
0029970981
-
P53 and angiogenesis
-
Bouck N: P53 and angiogenesis. Biochim Biophys Acta 1287:63-66, 1996
-
(1996)
Biochim Biophys Acta
, vol.1287
, pp. 63-66
-
-
Bouck, N.1
-
16
-
-
0028060380
-
Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
-
Dameron K, Volpert O, Tainsky M, Bouck N: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584, 1994
-
(1994)
Science
, vol.265
, pp. 1582-1584
-
-
Dameron, K.1
Volpert, O.2
Tainsky, M.3
Bouck, N.4
-
17
-
-
0030812331
-
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
-
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J, Valent A, Minty A, Chalon P, Lelias J, Dumont X, Ferrara P, McKeon F, Caput D: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819, 1997
-
(1997)
Cell
, vol.90
, pp. 809-819
-
-
Kaghad, M.1
Bonnet, H.2
Yang, A.3
Creancier, L.4
Biscan, J.5
Valent, A.6
Minty, A.7
Chalon, P.8
Lelias, J.9
Dumont, X.10
Ferrara, P.11
McKeon, F.12
Caput, D.13
-
18
-
-
0028038019
-
Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles
-
Runnebaum I, Yee J-K, Kieback D, Sukumar S, Friedmann T: Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles. Anticancer Res 14:1137-1144, 1994
-
(1994)
Anticancer Res
, vol.14
, pp. 1137-1144
-
-
Runnebaum, I.1
Yee, J.-K.2
Kieback, D.3
Sukumar, S.4
Friedmann, T.5
-
19
-
-
0026801062
-
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
-
Livingstone L, White A, Sprouse J, Livanos E, Jacks T, Tlsty T: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935, 1992
-
(1992)
Cell
, vol.70
, pp. 923-935
-
-
Livingstone, L.1
White, A.2
Sprouse, J.3
Livanos, E.4
Jacks, T.5
Tlsty, T.6
-
20
-
-
0025040367
-
Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53
-
Mercer W, Shields M, Amin M, Sauve G, Appella E, Romano J, Ullrich S, et al: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci 87:6166-6170, 1990
-
(1990)
Proc Natl Acad Sci
, vol.87
, pp. 6166-6170
-
-
Mercer, W.1
Shields, M.2
Amin, M.3
Sauve, G.4
Appella, E.5
Romano, J.6
Ullrich, S.7
-
21
-
-
0028169994
-
p53-dependent apoptosis suppresses tumor growth and progression in vivo
-
Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703-711, 1994
-
(1994)
Cell
, vol.78
, pp. 703-711
-
-
Symonds, H.1
Krall, L.2
Remington, L.3
Saenz-Robles, M.4
Lowe, S.5
Jacks, T.6
Van Dyke, T.7
-
22
-
-
0030025773
-
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
-
Graeber T, Osmanian C, Jacks T, Housman D, Koch C, Lowe S, Giaccia A: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91, 1996
-
(1996)
Nature
, vol.379
, pp. 88-91
-
-
Graeber, T.1
Osmanian, C.2
Jacks, T.3
Housman, D.4
Koch, C.5
Lowe, S.6
Giaccia, A.7
-
23
-
-
0025817813
-
Maintenance of p53 alterations throughout breast cancer progression
-
Davidoff A, Kerns B, Inglehard J, Marks J: Maintenance of p53 alterations throughout breast cancer progression. Cancer Res 51:2605-2610, 1991
-
(1991)
Cancer Res
, vol.51
, pp. 2605-2610
-
-
Davidoff, A.1
Kerns, B.2
Inglehard, J.3
Marks, J.4
-
24
-
-
0002791475
-
Biologic and genetic features of in situ breast cancer
-
Silverstein M (ed). Williams and Wilkins
-
Allred DC, Berardo M, Prosser J, O'Connell P: Biologic and genetic features of in situ breast cancer. In: Silverstein M. (ed) Ductal Carcinoma In Situ of the Breast. Williams and Wilkins, 1997, pp 37-49
-
(1997)
Ductal Carcinoma in Situ of the Breast
, pp. 37-49
-
-
Allred, D.C.1
Berardo, M.2
Prosser, J.3
O'Connell, P.4
-
25
-
-
0345229298
-
WAF1/CIP1 and p53 in human primary breast cancers: Associations with clinical, histologic, molecular and outcome data
-
WAF1/CIP1 and p53 in human primary breast cancers: associations with clinical, histologic, molecular and outcome data. Breast Cancer Res Treat 46:29, 1997
-
(1997)
Breast Cancer Res Treat
, vol.46
, pp. 29
-
-
Liu, S.1
Edgerton, S.2
Moore, D.3
Shi, Q.4
Thor, A.5
-
26
-
-
0027361822
-
Prognostic significance of p53 gene alterations in node-negative breast cancer
-
Elledge R, Fuqua S, Clark GM, Pujol P, Allred DC, McGuire W: Prognostic significance of p53 gene alterations in node-negative breast cancer. Breast Cancer Res Treat 26:225-235, 1993
-
(1993)
Breast Cancer Res Treat
, vol.26
, pp. 225-235
-
-
Elledge, R.1
Fuqua, S.2
Clark, G.M.3
Pujol, P.4
Allred, D.C.5
McGuire, W.6
-
27
-
-
0029073858
-
Prognostic significance of p53 overexpression in primary breast cancer: A novel luminometric immunoassay applicable on steroid receptor cytosols
-
Borg A, Lennerstrand J, Stenmark-Askmalm M, Ferno M, Brisfors A, Ohrvik A, Stal O, Killander D, Lane D, Brundell J: Prognostic significance of p53 overexpression in primary breast cancer: a novel luminometric immunoassay applicable on steroid receptor cytosols. Br J Cancer 71:1013-1017, 1995
-
(1995)
Br J Cancer
, vol.71
, pp. 1013-1017
-
-
Borg, A.1
Lennerstrand, J.2
Stenmark-Askmalm, M.3
Ferno, M.4
Brisfors, A.5
Ohrvik, A.6
Stal, O.7
Killander, D.8
Lane, D.9
Brundell, J.10
-
28
-
-
0029908595
-
TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients
-
Berns E, Klijn J, Smid M, van Staveren I, Look M, van Putten W, Foekens J: TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chrom & Cancer 16:170-179, 1996
-
(1996)
Genes Chrom & Cancer
, vol.16
, pp. 170-179
-
-
Berns, E.1
Klijn, J.2
Smid, M.3
Van Staveren, I.4
Look, M.5
Van Putten, W.6
Foekens, J.7
-
29
-
-
0027278584
-
Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?
-
Barnes D, Dublin E, Fisher C, Levison D, Millis R: Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum Path 24:469-476, 1993
-
(1993)
Hum Path
, vol.24
, pp. 469-476
-
-
Barnes, D.1
Dublin, E.2
Fisher, C.3
Levison, D.4
Millis, R.5
-
30
-
-
0027217515
-
Prognostic significance of p53 and c-erbB-2 expression in operable breast cancer
-
Noguchi M, Kitagawa H, Kinoshita K, Miyazaki I, Saito Y, Mizukami Y: Prognostic significance of p53 and c-erbB-2 expression in operable breast cancer. Int J Oncol 2:587-591, 1993
-
(1993)
Int J Oncol
, vol.2
, pp. 587-591
-
-
Noguchi, M.1
Kitagawa, H.2
Kinoshita, K.3
Miyazaki, I.4
Saito, Y.5
Mizukami, Y.6
-
31
-
-
0025739263
-
Nuclear p53 immunoreaction associated with poor prognosis of breast cancer
-
Iwaya K, Tsuda H, Hiraide H, Tamaki K, Tamakuma S, Fukutomi T, Mukai K, Hirohashi S: Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Cancer Res 82:835-840, 1991
-
(1991)
Jpn J Cancer Res
, vol.82
, pp. 835-840
-
-
Iwaya, K.1
Tsuda, H.2
Hiraide, H.3
Tamaki, K.4
Tamakuma, S.5
Fukutomi, T.6
Mukai, K.7
Hirohashi, S.8
-
32
-
-
0028227085
-
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
-
Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12:454-466, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 454-466
-
-
Gasparini, G.1
Weidner, N.2
Bevilacqua, P.3
Maluta, S.4
Palma, P.5
Caffo, O.6
Barbareschi, M.7
Boracchi, P.8
Marubini, E.9
Pozza, F.10
-
33
-
-
0028205012
-
Cellular accumulation of p53 protein: An independent prognostic factor in stage II breast cancer
-
Stenmark-Askmalm M, Stål O, Sullivan S, Ferraud L, Sun X, Carstensen J, Nordenskjöld B: Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer. Eur J Cancer 30A(2):175-180, 1994
-
(1994)
Eur J Cancer
, vol.30 A
, Issue.2
, pp. 175-180
-
-
Stenmark-Askmalm, M.1
Stål, O.2
Sullivan, S.3
Ferraud, L.4
Sun, X.5
Carstensen, J.6
Nordenskjöld, B.7
-
34
-
-
0029948890
-
Node negative breast carcinoma: Hyperprolactinemia and/or over-expression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators
-
Patel D, Bhatavdekar J, Chikhlikar P, Ghosh N, Suthar T, Shah N, Mehta R, Balar D: Node negative breast carcinoma: Hyperprolactinemia and/or over-expression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators. J Surg Oncol 62:86-92, 1996
-
(1996)
J Surg Oncol
, vol.62
, pp. 86-92
-
-
Patel, D.1
Bhatavdekar, J.2
Chikhlikar, P.3
Ghosh, N.4
Suthar, T.5
Shah, N.6
Mehta, R.7
Balar, D.8
-
35
-
-
0027935395
-
p53 gene mutations in breast cancers in midwestern US women: Null as well as missense-type mutations are associated with poor prognosis
-
Saitoh S, Cunningham J, De Vries E, McGovern R, Schroeder J, Hartmann A, Blaszyk H, Wold L, Schaid D, Sommer S, Kovach J: p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis. Oncogene 9:2869-2875, 1994
-
(1994)
Oncogene
, vol.9
, pp. 2869-2875
-
-
Saitoh, S.1
Cunningham, J.2
De Vries, E.3
McGovern, R.4
Schroeder, J.5
Hartmann, A.6
Blaszyk, H.7
Wold, L.8
Schaid, D.9
Sommer, S.10
Kovach, J.11
-
36
-
-
0028436070
-
p53 gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: Correlation between immunohistochemical and molecular biology techniques
-
Hurlimann J, Chaubert P, Benhattar J: p53 gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: Correlation between immunohistochemical and molecular biology techniques. Mod Path 7(4):423-428, 1994
-
(1994)
Mod Path
, vol.7
, Issue.4
, pp. 423-428
-
-
Hurlimann, J.1
Chaubert, P.2
Benhattar, J.3
-
37
-
-
0030029626
-
p53 protein as a prognostic indicator in breast carcinoma: A comparison of four antibodies for immunohistochemistry
-
Horne G, Anderson J, Tiniakos D, McIntosh G, Thomas M, Angus B, Henry J, Lennard T, Horne C: p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry. Br J Cancer 73:29-35, 1996
-
(1996)
Br J Cancer
, vol.73
, pp. 29-35
-
-
Horne, G.1
Anderson, J.2
Tiniakos, D.3
McIntosh, G.4
Thomas, M.5
Angus, B.6
Henry, J.7
Lennard, T.8
Horne, C.9
-
38
-
-
0030058617
-
The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
-
Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L, Bergh J: The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 88:173-182, 1996
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 173-182
-
-
Sjogren, S.1
Inganas, M.2
Norberg, T.3
Lindgren, A.4
Nordgren, H.5
Holmberg, L.6
Bergh, J.7
-
39
-
-
0027183592
-
Prognostic significance of TP53 alterations in breast carcinoma
-
Andersen T, Holm R, Nesland J, Heimdal K, Ottestad L, Borresen A: Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer 68:540-548, 1993
-
(1993)
Br J Cancer
, vol.68
, pp. 540-548
-
-
Andersen, T.1
Holm, R.2
Nesland, J.3
Heimdal, K.4
Ottestad, L.5
Borresen, A.6
-
40
-
-
0028859565
-
TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis
-
Thorlacius S, Thorgilsson B, Bjornsson J, Tryggvadottir L, Borresen A, Ogmundsdottir H, Eyfjord J: TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis. Eur J Cancer 31A:1856-1861, 1995
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 1856-1861
-
-
Thorlacius, S.1
Thorgilsson, B.2
Bjornsson, J.3
Tryggvadottir, L.4
Borresen, A.5
Ogmundsdottir, H.6
Eyfjord, J.7
-
41
-
-
0030013978
-
Prognostic significance of TP53 accumulation in human primary breast cancer: Comparison between a rapid quantitative immunoassay and SSCP analysis
-
deWitte H, Foekens J, Lennerstrand J, Smid M, Look M, Klun J, Benraad T, Berns E: Prognostic significance of TP53 accumulation in human primary breast cancer: Comparison between a rapid quantitative immunoassay and SSCP analysis. Int J Cancer (Pred. Oncol.) 69:125-130, 1996
-
(1996)
Int J Cancer (Pred. Oncol.)
, vol.69
, pp. 125-130
-
-
DeWitte, H.1
Foekens, J.2
Lennerstrand, J.3
Smid, M.4
Look, M.5
Klun, J.6
Benraad, T.7
Berns, E.8
-
42
-
-
0028209683
-
Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer
-
Marks J, Humphrey P, Wu K, Berry D, Banderenko N, Kerns B, Inglehart J: Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer. Ann Surg 219(4):332-341, 1994
-
(1994)
Ann Surg
, vol.219
, Issue.4
, pp. 332-341
-
-
Marks, J.1
Humphrey, P.2
Wu, K.3
Berry, D.4
Banderenko, N.5
Kerns, B.6
Inglehart, J.7
-
43
-
-
0026738802
-
Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer. An immunohistochemical study
-
Sawan A, Randall B, Angus B, Wright C, Henry J, Ostrowski J, Hennessy C, Lennard T, Corbett I, Horne C: Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer. An immunohistochemical study. J Path 168:23-28, 1992
-
(1992)
J Path
, vol.168
, pp. 23-28
-
-
Sawan, A.1
Randall, B.2
Angus, B.3
Wright, C.4
Henry, J.5
Ostrowski, J.6
Hennessy, C.7
Lennard, T.8
Corbett, I.9
Horne, C.10
-
44
-
-
0030002609
-
Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis
-
Seshadri R, Leong A, McCaul K, Firgaira F, Setlur V, Horsfall D: Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis. Int J Cancer (Pred. Oncol.) 69:135-141, 1996
-
(1996)
Int J Cancer (Pred. Oncol.)
, vol.69
, pp. 135-141
-
-
Seshadri, R.1
Leong, A.2
McCaul, K.3
Firgaira, F.4
Setlur, V.5
Horsfall, D.6
-
45
-
-
0028984911
-
p53 as a prognostic factor in stage I breast cancer
-
Stenmark-Askmalm M, Stål O, Olsen K, Nordenskjöld B, South-East Sweden Breast Cancer Group: p53 as a prognostic factor in stage I breast cancer. Cancer 72:715-719, 1995
-
(1995)
Cancer
, vol.72
, pp. 715-719
-
-
Stenmark-Askmalm, M.1
Stål, O.2
Olsen, K.3
Nordenskjöld, B.4
-
46
-
-
0345043270
-
Immunohistochemical detection of p53 and cerb-B-2 proteins: Prognostic significance in operable breast cancer
-
Takikawa Y, Noguchi M, Kitagawa H, Thomas M: Immunohistochemical detection of p53 and cerb-B-2 proteins: Prognostic significance in operable breast cancer. Breast Cancer 1:17-23, 1994
-
(1994)
Breast Cancer
, vol.1
, pp. 17-23
-
-
Takikawa, Y.1
Noguchi, M.2
Kitagawa, H.3
Thomas, M.4
-
47
-
-
0027155550
-
p53 as an independent prognostic marker in lymph node-negative breast cancer patients
-
Silvestrini R, Benini E, Daidone M, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U: p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85:965-970, 1993
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 965-970
-
-
Silvestrini, R.1
Benini, E.2
Daidone, M.3
Veneroni, S.4
Boracchi, P.5
Cappelletti, V.6
Di Fronzo, G.7
Veronesi, U.8
-
48
-
-
0027976281
-
Prognostic value of p53 expression in early-stage breast carcinoma compared with tumour angiogenesis, epidermal growth factor receptor, c-erbB-2, cathepsin D, DNA ploidy, parameters of cell kinetics and conventional features
-
Gasparini G, Bevilacqua P, Boracchi P, Maluta S, Pozza F, Barbareschi M, Palma P, Mezzetti M, Harris A: Prognostic value of p53 expression in early-stage breast carcinoma compared with tumour angiogenesis, epidermal growth factor receptor, c-erbB-2, cathepsin D, DNA ploidy, parameters of cell kinetics and conventional features. Int J Oncol 4:155-162, 1994
-
(1994)
Int J Oncol
, vol.4
, pp. 155-162
-
-
Gasparini, G.1
Bevilacqua, P.2
Boracchi, P.3
Maluta, S.4
Pozza, F.5
Barbareschi, M.6
Palma, P.7
Mezzetti, M.8
Harris, A.9
-
49
-
-
0027377932
-
Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast
-
Visscher D, Sarkar F, Wykes S, Kothari K, Macoska J, Crissman J: Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast. Arch Pathol Lab Med 117:973-976, 1993
-
(1993)
Arch Pathol Lab Med
, vol.117
, pp. 973-976
-
-
Visscher, D.1
Sarkar, F.2
Wykes, S.3
Kothari, K.4
Macoska, J.5
Crissman, J.6
-
50
-
-
0027143621
-
Overexpression of p53 and prognosis in breast cancer
-
Friedrichs K, Gluba S, Eidtmann H, Jonat W: Overexpression of p53 and prognosis in breast cancer. Cancer 72:3641-3647, 1993
-
(1993)
Cancer
, vol.72
, pp. 3641-3647
-
-
Friedrichs, K.1
Gluba, S.2
Eidtmann, H.3
Jonat, W.4
-
51
-
-
0028812722
-
Expression of p53 protein has no independent prognostic value in breast cancer
-
Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V-M, Syrjänen K: Expression of p53 protein has no independent prognostic value in breast cancer. J Path 177:225-232, 1995
-
(1995)
J Path
, vol.177
, pp. 225-232
-
-
Pietiläinen, T.1
Lipponen, P.2
Aaltomaa, S.3
Eskelinen, M.4
Kosma, V.-M.5
Syrjänen, K.6
-
52
-
-
0028999446
-
p53 protein in 204 patients with primary breast carcinoma - Immunohistochemical detection and clinical value as a prognostic factor
-
Göhring U-J, Scharl A. Heckel C, Ahr A, Combach G: p53 protein in 204 patients with primary breast carcinoma - immunohistochemical detection and clinical value as a prognostic factor. Arch Gynecol Obstet 256:139-146, 1995
-
(1995)
Arch Gynecol Obstet
, vol.256
, pp. 139-146
-
-
Göhring, U.-J.1
Scharl, A.2
Heckel, C.3
Ahr, A.4
Combach, G.5
-
53
-
-
0001428461
-
Overexpression of p53 in node-positive breast cancer
-
Alfred DC, Clark G, Fuqua S, Elledge R, Hilsenbeck S, Ravdin P, Yee D, Chamness GC, Osborne CK: Overexpression of p53 in node-positive breast cancer. Breast Cancer Res Treat 27:131, 1993
-
(1993)
Breast Cancer Res Treat
, vol.27
, pp. 131
-
-
Alfred, D.C.1
Clark, G.2
Fuqua, S.3
Elledge, R.4
Hilsenbeck, S.5
Ravdin, P.6
Yee, D.7
Chamness, G.C.8
Osborne, C.K.9
-
54
-
-
0027481931
-
Somatic p53 mutations in human breast carcinomas in an Icelandic population: A prognostic factor
-
Thorlacius S, Börresen A-L, Eyfjörd J: Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Cancer Res 53:1637-1641, 1993
-
(1993)
Cancer Res
, vol.53
, pp. 1637-1641
-
-
Thorlacius, S.1
Börresen, A.-L.2
Eyfjörd, J.3
-
55
-
-
0026659891
-
Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients
-
Isola J, Visakorpi T, Holli K, Kallioniemi O-P: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. JNCI 84:1109-1114, 1992
-
(1992)
JNCI
, vol.84
, pp. 1109-1114
-
-
Isola, J.1
Visakorpi, T.2
Holli, K.3
Kallioniemi, O.-P.4
-
56
-
-
0029042673
-
Prognostic value of p53 in breast invasive ductal carcinoma: An immuno-histochemical study on 942 cases
-
MacGrogan G, Bonichon F, Mascarel I, Trojani M, Durand M, Avril A, Coindre J: Prognostic value of p53 in breast invasive ductal carcinoma: an immuno-histochemical study on 942 cases. Breast Cancer Res Treat 36:71-81, 1995
-
(1995)
Breast Cancer Res Treat
, vol.36
, pp. 71-81
-
-
MacGrogan, G.1
Bonichon, F.2
Mascarel, I.3
Trojani, M.4
Durand, M.5
Avril, A.6
Coindre, J.7
-
57
-
-
0027394794
-
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
-
Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown R, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. JNCI 85:200-206, 1993
-
(1993)
JNCI
, vol.85
, pp. 200-206
-
-
Allred, D.C.1
Clark, G.M.2
Elledge, R.3
Fuqua, S.A.W.4
Brown, R.5
Chamness, G.C.6
Osborne, C.K.7
McGuire, W.L.8
-
58
-
-
0026724877
-
Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
-
Thor A, Moore D, Edgerton S, Kawasaki E, Reihsaus E, Lynch H, Marcus I, Schwartz L, Chen L-C, Mayall B, Smith H: Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. JNCI 84:845-855, 1992
-
(1992)
JNCI
, vol.84
, pp. 845-855
-
-
Thor, A.1
Moore, D.2
Edgerton, S.3
Kawasaki, E.4
Reihsaus, E.5
Lynch, H.6
Marcus, I.7
Schwartz, L.8
Chen, L.-C.9
Mayall, B.10
Smith, H.11
-
59
-
-
0344798297
-
TP53 gene alterations in human primary breast cancer: Mutational spectrum analysis and prognostic value
-
van Staveren I, Foekens J, Klijn J, Smid M, Look M, Meijer-van Gelder M, Berns P: TP53 gene alterations in human primary breast cancer: mutational spectrum analysis and prognostic value. Proc Am Assoc Cancer Res 37:3904, 1996
-
(1996)
Proc Am Assoc Cancer Res
, vol.37
, pp. 3904
-
-
Van Staveren, I.1
Foekens, J.2
Klijn, J.3
Smid, M.4
Look, M.5
Meijer-Van Gelder, M.6
Berns, P.7
-
60
-
-
0026795005
-
p53 protein expression in human breast carcinoma: Relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor
-
Poller D, Hatchings C, Galea M, Bell J, Nicholson R, Elston C, Blamey R, Ellis I: p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor. Br J Cancer 66:583-588, 1992
-
(1992)
Br J Cancer
, vol.66
, pp. 583-588
-
-
Poller, D.1
Hatchings, C.2
Galea, M.3
Bell, J.4
Nicholson, R.5
Elston, C.6
Blamey, R.7
Ellis, I.8
-
61
-
-
0031471966
-
Detection of p53 gene mutation by rapid PCS-SSCP and its association with poor survival in breast cancer
-
Soong R, Iacopetta B, Harvey J, Sterrett G, Dawkins H, Hahnel R, Robbins P: Detection of p53 gene mutation by rapid PCS-SSCP and its association with poor survival in breast cancer. Int J Cancer 74:642-647, 1997
-
(1997)
Int J Cancer
, vol.74
, pp. 642-647
-
-
Soong, R.1
Iacopetta, B.2
Harvey, J.3
Sterrett, G.4
Dawkins, H.5
Hahnel, R.6
Robbins, P.7
-
62
-
-
0025802994
-
p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study
-
Ostrowski J, Sawan A, Henry L, Wright C, Henry J, Hennessy C, Lennard T, Angus B, Horne C: p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol 164:75-81, 1991
-
(1991)
J Pathol
, vol.164
, pp. 75-81
-
-
Ostrowski, J.1
Sawan, A.2
Henry, L.3
Wright, C.4
Henry, J.5
Hennessy, C.6
Lennard, T.7
Angus, B.8
Horne, C.9
-
63
-
-
0028670132
-
p53 gene expression in node-positive breast cancer: Relationship to DNA ploidy and prognosis
-
Cunningham J, Ingle J, Jung S, Cha S, Wold L, Farr G, Witzig T, Krook J, Wieand H, Kobvach J: p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis. J Natl Cancer Inst 86:1871-1873, 1994
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 1871-1873
-
-
Cunningham, J.1
Ingle, J.2
Jung, S.3
Cha, S.4
Wold, L.5
Farr, G.6
Witzig, T.7
Krook, J.8
Wieand, H.9
Kobvach, J.10
-
64
-
-
0029665943
-
WAF1 immunohistochemical expression in breast carcinoma: Correlation with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival
-
WAF1 immunohistochemical expression in breast carcinoma: correlation with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer 74:208-215, 1996
-
(1996)
Br J Cancer
, vol.74
, pp. 208-215
-
-
Barbareschi, M.1
Caffo, O.2
Doglioni, C.3
Fina, P.4
Mar-Chetti, A.5
Buttitta, F.6
Leek, R.7
Morelli, L.8
Leonardi, E.9
Bevilacqua, G.10
Dalla Palma, P.11
Harris, L.12
-
65
-
-
0028346606
-
p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: Comparison of staining and PCR-SSCP results
-
Jacquemier J, Moles J, Penault-Llorca F, Adelaide J, Torrente M, Viens P, Birnbaum D, Theillet C: p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br J Cancer 69:846-852, 1994
-
(1994)
Br J Cancer
, vol.69
, pp. 846-852
-
-
Jacquemier, J.1
Moles, J.2
Penault-Llorca, F.3
Adelaide, J.4
Torrente, M.5
Viens, P.6
Birnbaum, D.7
Theillet, C.8
-
66
-
-
0029757392
-
TP53 mutation analyses on breast carcinomas: A study of paraffinembedded archival material
-
Gretarsdottir S, Tryggvadottir L, Jonasson JG, Sigurdsson H, Olafsdottir K, Agnarsson B, Ogmundsdottir H, Eyfjord JE: TP53 mutation analyses on breast carcinomas: a study of paraffinembedded archival material. Br J Cancer 74:555-561, 1996
-
(1996)
Br J Cancer
, vol.74
, pp. 555-561
-
-
Gretarsdottir, S.1
Tryggvadottir, L.2
Jonasson, J.G.3
Sigurdsson, H.4
Olafsdottir, K.5
Agnarsson, B.6
Ogmundsdottir, H.7
Eyfjord, J.E.8
-
67
-
-
0027054864
-
Immunohisto-chemical detection of mutant p53-suppressor gene product in patients with breast cancer: Influence on metastasis-free survival
-
Hanzal E, Gitsch G, Kohlberger P, Dadak C, Miechowiecka N, Breitenecker G: Immunohisto-chemical detection of mutant p53-suppressor gene product in patients with breast cancer: Influence on metastasis-free survival. Anticancer Res 12:2325-2330, 1992
-
(1992)
Anticancer Res
, vol.12
, pp. 2325-2330
-
-
Hanzal, E.1
Gitsch, G.2
Kohlberger, P.3
Dadak, C.4
Miechowiecka, N.5
Breitenecker, G.6
-
68
-
-
0027324298
-
p53 protein expression in breast cancer as related to histopathological characteristics and prognosis
-
Lipponen P, Ji H, Aaltomaa S, Syrjanen S, Syrjanen K: p53 protein expression in breast cancer as related to histopathological characteristics and prognosis. Int J Cancer 55:51-56, 1993
-
(1993)
Int J Cancer
, vol.55
, pp. 51-56
-
-
Lipponen, P.1
Ji, H.2
Aaltomaa, S.3
Syrjanen, S.4
Syrjanen, K.5
-
69
-
-
24244437593
-
p53 oncosuppressor protein in carcinoma of the breast
-
Masood S, Barnes R, Villas B, Wilson W, Shi S, Clark G, Tandon A: p53 oncosuppressor protein in carcinoma of the breast. Lab Invest 68:17A, 1993
-
(1993)
Lab Invest
, vol.68
-
-
Masood, S.1
Barnes, R.2
Villas, B.3
Wilson, W.4
Shi, S.5
Clark, G.6
Tandon, A.7
-
70
-
-
0028027567
-
Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients
-
Wiltschke C, Kindas-Muegge I, Steininger A, Reiner A, Reiner G, Preis P: Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients. Clin Res Clin Oncol 737-742, 1994
-
(1994)
Clin Res Clin Oncol
, pp. 737-742
-
-
Wiltschke, C.1
Kindas-Muegge, I.2
Steininger, A.3
Reiner, A.4
Reiner, G.5
Preis, P.6
-
71
-
-
0028986873
-
p53 in node-negative breast carcinoma: An immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis
-
Rosen PR, Lesser ML, Arroyo CD, Cranor M, Borgen P, Norton L: p53 in node-negative breast carcinoma: An immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J Clin Oncol 13:821-830, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 821-830
-
-
Rosen, P.R.1
Lesser, M.L.2
Arroyo, C.D.3
Cranor, M.4
Borgen, P.5
Norton, L.6
-
72
-
-
0029927099
-
Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer
-
Nakopoulou L, Alexiadou A, Theodoropoulos G, Lazaris A, Tzonou A, Keramopoulos A: Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer. J Pathol 179:31-38, 1996
-
(1996)
J Pathol
, vol.179
, pp. 31-38
-
-
Nakopoulou, L.1
Alexiadou, A.2
Theodoropoutos, G.3
Lazaris, A.4
Tzonou, A.5
Keramopoulos, A.6
-
73
-
-
0028173703
-
p53 gene mutations and steroid receptor status in breast cancer
-
Caleffi M, Teague M, Jensen R, Vnencak-Jones C, Dupont W, Parl F: p53 gene mutations and steroid receptor status in breast cancer. Cancer 73:2147-2156, 1994
-
(1994)
Cancer
, vol.73
, pp. 2147-2156
-
-
Caleffi, M.1
Teague, M.2
Jensen, R.3
Vnencak-Jones, C.4
Dupont, W.5
Parl, F.6
-
74
-
-
0027942222
-
p53 protein and vimentin in invasive ductal NOS breast carcinoma - Relationship with survival and sites of metastases
-
Domagala W, Striker G, Szadowska A, Dukowicz A, Harezga B, Osborn M: p53 protein and vimentin in invasive ductal NOS breast carcinoma - relationship with survival and sites of metastases. Eur J Cancer 30A:1527-1534, 1994
-
(1994)
Eur J Cancer
, vol.30 A
, pp. 1527-1534
-
-
Domagala, W.1
Striker, G.2
Szadowska, A.3
Dukowicz, A.4
Harezga, B.5
Osborn, M.6
-
75
-
-
0026471731
-
Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up
-
Bosari S, Lee A, Viale G, Heatley G, Coggi G: Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up. Virchows Archiv A Pathol Anat 421:291-295, 1992
-
(1992)
Virchows Archiv a Pathol Anat
, vol.421
, pp. 291-295
-
-
Bosari, S.1
Lee, A.2
Viale, G.3
Heatley, G.4
Coggi, G.5
-
76
-
-
0028948129
-
An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis
-
Haerslev T, Jacobsen G: An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis. Hum Pathol 26:295-301, 1995
-
(1995)
Hum Pathol
, vol.26
, pp. 295-301
-
-
Haerslev, T.1
Jacobsen, G.2
-
77
-
-
0030596311
-
Assessing p53 status in breast cancer prognosis: Where should you put the thermometer if you think your p53 is sick?
-
Elledge R: Assessing p53 status in breast cancer prognosis: where should you put the thermometer if you think your p53 is sick? J Natl Cancer Inst 88:141-143, 1996
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 141-143
-
-
Elledge, R.1
-
78
-
-
0030053794
-
Abnormal expression of MDM-2 in breast carcinomas
-
Bueso-Ramos C, Manshouri T, Haidar M, Yang Y, McCown P, Ordonez N, Glassman A, Sneige N, Albitar M: Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res Treat 37:179-188, 1996
-
(1996)
Breast Cancer Res Treat
, vol.37
, pp. 179-188
-
-
Bueso-Ramos, C.1
Manshouri, T.2
Haidar, M.3
Yang, Y.4
McCown, P.5
Ordonez, N.6
Glassman, A.7
Sneige, N.8
Albitar, M.9
-
79
-
-
0026649648
-
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
-
Momand J, Zambetti G, Olson D, George D, Levine A: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-11245, 1992
-
(1992)
Cell
, vol.69
, pp. 1237-11245
-
-
Momand, J.1
Zambetti, G.2
Olson, D.3
George, D.4
Levine, A.5
-
80
-
-
0029742823
-
Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer
-
Jacobs T, Prioleau J, Stillman I, Schnitt S: Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88:1054-1059, 1996
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1054-1059
-
-
Jacobs, T.1
Prioleau, J.2
Stillman, I.3
Schnitt, S.4
-
81
-
-
0028142049
-
p53 protein accumulation detected by five different antibodies: Relationship to prognosis and heat shock protein 70 in breast cancer
-
Elledge R, Clark GM, Fuqua SAW, Yu Y-Y, Allred DC: p53 protein accumulation detected by five different antibodies: Relationship to prognosis and heat shock protein 70 in breast cancer. Cancer Res 54:3752-3757, 1994
-
(1994)
Cancer Res
, vol.54
, pp. 3752-3757
-
-
Elledge, R.1
Clark, G.M.2
Fuqua, S.A.W.3
Yu, Y.-Y.4
Allred, D.C.5
-
82
-
-
10244261646
-
Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers
-
Hayes D, Bast R, Desch C, Fritsche H, Kemeny N, Jessup J, Locker G, Macdonald J, Mennel R, Norton L, Ravdin P, Taube S, Winn R: Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 88:1456-1466, 1996
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1456-1466
-
-
Hayes, D.1
Bast, R.2
Desch, C.3
Fritsche, H.4
Kemeny, N.5
Jessup, J.6
Locker, G.7
Macdonald, J.8
Mennel, R.9
Norton, L.10
Ravdin, P.11
Taube, S.12
Winn, R.13
-
83
-
-
0342887306
-
Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer
-
Kuukasjärvi T, Karhu R, Tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi O, Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57:1597-1604, 1997
-
(1997)
Cancer Res
, vol.57
, pp. 1597-1604
-
-
Kuukasjärvi, T.1
Karhu, R.2
Tanner, M.3
Kähkönen, M.4
Schäffer, A.5
Nupponen, N.6
Pennanen, S.7
Kallioniemi, A.8
Kallioniemi, O.9
Isola, J.10
-
84
-
-
0028652334
-
Breast cancer response to adjuvant chemotherapy in correlation with erbB2 and p53 expression
-
Jacquemier J, Penault-Llorca F, Viens P, Houvenaeghel G, Hassoun J, Torrente M, Adelaide J, Birnbaum D: Breast cancer response to adjuvant chemotherapy in correlation with erbB2 and p53 expression. Anticancer Res 14:2773-2778, 1994
-
(1994)
Anticancer Res
, vol.14
, pp. 2773-2778
-
-
Jacquemier, J.1
Penault-Llorca, F.2
Viens, P.3
Houvenaeghel, G.4
Hassoun, J.5
Torrente, M.6
Adelaide, J.7
Birnbaum, D.8
-
85
-
-
0028804760
-
p53 expression and the result of adjuvant therapy of breast cancer
-
Stal O, Askmalm M, Wingren S, Rutqvist L, Skoog L, Ferraud L, Sullivan S, Carstensen J, Nordenskjold B: p53 expression and the result of adjuvant therapy of breast cancer. Acta Oncologica 34:767-770, 1995
-
(1995)
Acta Oncologica
, vol.34
, pp. 767-770
-
-
Stal, O.1
Askmalm, M.2
Wingren, S.3
Rutqvist, L.4
Skoog, L.5
Ferraud, L.6
Sullivan, S.7
Carstensen, J.8
Nordenskjold, B.9
-
86
-
-
0028949829
-
p53 and c-erbB-2 expression and response to preoperative chemotherapy in locally advanced breast carcinoma
-
Resnick J, Sneige N, Kemp B, Sahin A, Ordonez N, Frye D, Hortobagyi G: p53 and c-erbB-2 expression and response to preoperative chemotherapy in locally advanced breast carcinoma. Breast Dis 8:149-158, 1995
-
(1995)
Breast Dis
, vol.8
, pp. 149-158
-
-
Resnick, J.1
Sneige, N.2
Kemp, B.3
Sahin, A.4
Ordonez, N.5
Frye, D.6
Hortobagyi, G.7
-
87
-
-
0029956081
-
Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
-
Aas T, Borresen A, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug J, Akslen L, Lonning P: Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2:811-814, 1996
-
(1996)
Nat Med
, vol.2
, pp. 811-814
-
-
Aas, T.1
Borresen, A.2
Geisler, S.3
Smith-Sorensen, B.4
Johnsen, H.5
Varhaug, J.6
Akslen, L.7
Lonning, P.8
-
88
-
-
0029848257
-
Primary chemotherapy in breast invasive carcinoma: Predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GSTπ
-
MacGrogan G, Mauriac L, Durand M, Bonichon F, Trojani M, de Mascarel I, Coindre J: Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GSTπ. Br J Cancer 74:1458-1465, 1996
-
(1996)
Br J Cancer
, vol.74
, pp. 1458-1465
-
-
MacGrogan, G.1
Mauriac, L.2
Durand, M.3
Bonichon, F.4
Trojani, M.5
De Mascarel, I.6
Coindre, J.7
-
89
-
-
0028176804
-
p53 mutations and overexpression in locally advanced breast cancers
-
Faille A, De Cremoux P, Extra J, Linares G, Espie M, Bourstyn E, De Rocquancourt A, Giacchetti S, Marty M, Calvo F: p53 mutations and overexpression in locally advanced breast cancers. Br J Cancer 69:1145-1150, 1994
-
(1994)
Br J Cancer
, vol.69
, pp. 1145-1150
-
-
Faille, A.1
De Cremoux, P.2
Extra, J.3
Linares, G.4
Espie, M.5
Bourstyn, E.6
De Rocquancourt, A.7
Giacchetti, S.8
Marty, M.9
Calvo, F.10
-
90
-
-
0028859453
-
p53 status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: A novel hypothesis based on clinical findings
-
Jansson T, Inganas M, Sjogren S, Norberg T, Lindgren A, Holmberg L, Bergh J: p53 status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings. J Clin Oncol 13:2745-2751, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 2745-2751
-
-
Jansson, T.1
Inganas, M.2
Sjogren, S.3
Norberg, T.4
Lindgren, A.5
Holmberg, L.6
Bergh, J.7
-
91
-
-
0030992313
-
Expression of p53, glutathione S-transferase-π, and bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer
-
Silvestrini R, Veneroni S, Benini E, Daidone M, Luisi A, Leutner M, Maucione A, Kenda R, Zucali R, Veronesi U: Expression of p53, glutathione S-transferase-π, and bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Natl Cancer Inst 89:639-645, 1997
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 639-645
-
-
Silvestrini, R.1
Veneroni, S.2
Benini, E.3
Daidone, M.4
Luisi, A.5
Leutner, M.6
Maucione, A.7
Kenda, R.8
Zucali, R.9
Veronesi, U.10
-
92
-
-
0028875410
-
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
-
Bergh J, Norberg T, Sjogren S, Lindgren A, Holmberg L: Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1:1029-1034, 1995
-
(1995)
Nat Med
, vol.1
, pp. 1029-1034
-
-
Bergh, J.1
Norberg, T.2
Sjogren, S.3
Lindgren, A.4
Holmberg, L.5
-
93
-
-
0031964170
-
Is p53 a protein that predicts the response to chemo-therapy in node negative breast cancer?
-
in press
-
Degeorges A, Roquancourt A, Extra J, Espie M, Bourstyn E, de Cremoux P, Soussi T, Marty M: Is p53 a protein that predicts the response to chemo-therapy in node negative breast cancer? Breast Cancer Res Treat, in press, 1998
-
(1998)
Breast Cancer Res Treat
-
-
Degeorges, A.1
Roquancourt, A.2
Extra, J.3
Espie, M.4
Bourstyn, E.5
De Cremoux, P.6
Soussi, T.7
Marty, M.8
-
94
-
-
0029155714
-
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer
-
Elledge R, Gray R, Mansour Yu Y, Clark G, Ravdin P, Osborne CK, Gilchrist K, Davidson N, Robert N, Tormey D, Allred DC: Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer. JNCI 87(16):1254-1256, 1995
-
(1995)
JNCI
, vol.87
, Issue.16
, pp. 1254-1256
-
-
Elledge, R.1
Gray, R.2
Mansour, Yu.Y.3
Clark, G.4
Ravdin, P.5
Osborne, C.K.6
Gilchrist, K.7
Davidson, N.8
Robert, N.9
Tormey, D.10
Allred, D.C.11
-
95
-
-
0030951877
-
bcl-2, p53, and response to tamoxifen in ER-positive metastatic breast cancer: A southwest oncology group study
-
in press
-
Elledge R, Green S, Howes L, Clark G, Berardo M, Allred DC, Pugh R, Ciocca D, Ravdin P, O'Sullivan J, Rivkin S, Martino S, Osborne CK: bcl-2, p53, and response to tamoxifen in ER-positive metastatic breast cancer: A Southwest Oncology Group study. J Clin Oncol, in press
-
J Clin Oncol
-
-
Elledge, R.1
Green, S.2
Howes, L.3
Clark, G.4
Berardo, M.5
Allred, D.C.6
Pugh, R.7
Ciocca, D.8
Ravdin, P.9
O'Sullivan, J.10
Rivkin, S.11
Martino, S.12
Osborne, C.K.13
-
96
-
-
0031982783
-
p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer
-
Berns E, Klijn J, van Putten W, de Witte H, Look M, Meijer-van Gelder M, Willman K, Portengen H, Benraad T, Foekens J: p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer. J Clin Oncol 16:121-127, 1998
-
(1998)
J Clin Oncol
, vol.16
, pp. 121-127
-
-
Berns, E.1
Klijn, J.2
Van Putten, W.3
De Witte, H.4
Look, M.5
Meijer-Van Gelder, M.6
Willman, K.7
Portengen, H.8
Benraad, T.9
Foekens, J.10
-
97
-
-
0028861009
-
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy
-
Archer S, Eliopoulos A, Spandidos D, Barnes D, Ellis I, Blamey R, Nicholson R, Robertson J: Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. Br J Cancer 72:1259-1266, 1995
-
(1995)
Br J Cancer
, vol.72
, pp. 1259-1266
-
-
Archer, S.1
Eliopoulos, A.2
Spandidos, D.3
Barnes, D.4
Ellis, I.5
Blamey, R.6
Nicholson, R.7
Robertson, J.8
-
98
-
-
0028354305
-
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
-
Muss H, Thor A, Berry D, Kute T, Liu E, Koerner F, Cirrincione C, Budman D, Wood W, Barcos M, Henderson I: c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 330:1260-1266, 1994
-
(1994)
N Engl J Med
, vol.330
, pp. 1260-1266
-
-
Muss, H.1
Thor, A.2
Berry, D.3
Kute, T.4
Liu, E.5
Koerner, F.6
Cirrincione, C.7
Budman, D.8
Wood, W.9
Barcos, M.10
Henderson, I.11
-
99
-
-
0031919283
-
p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer
-
Clahsen P, van de Velde C, Duval C, Pallud C, Mandard A-M, Delobelle-Deroide A, van den Broek L, Sahmoud T, van de Vijver M: p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer. J Clin Oncol 16(2):470-479, 1998
-
(1998)
J Clin Oncol
, vol.16
, Issue.2
, pp. 470-479
-
-
Clahsen, P.1
Van de Velde, C.2
Duval, C.3
Pallud, C.4
Mandard, A.-M.5
Delobelle-Deroide, A.6
Van den Broek, L.7
Sahmoud, T.8
Van de Vijver, M.9
-
100
-
-
0026088670
-
Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
-
Kyprianou N, English H, Davidson N, Isaacs J: Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51:162-166, 1991
-
(1991)
Cancer Res
, vol.51
, pp. 162-166
-
-
Kyprianou, N.1
English, H.2
Davidson, N.3
Isaacs, J.4
-
101
-
-
0027301384
-
Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro
-
Wärri A, Huovinen R, Laine A, Martikainen P, Härkönen P: Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. JNCI 85:1412-1418, 1993
-
(1993)
JNCI
, vol.85
, pp. 1412-1418
-
-
Wärri, A.1
Huovinen, R.2
Laine, A.3
Martikainen, P.4
Härkönen, P.5
-
102
-
-
0029303048
-
Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells
-
Perry R, Kang Y, Greaves B: Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann Surg Oncol 2(3):238-245, 1995
-
(1995)
Ann Surg Oncol
, vol.2
, Issue.3
, pp. 238-245
-
-
Perry, R.1
Kang, Y.2
Greaves, B.3
-
103
-
-
0028832408
-
p53 mutation and tamoxifen resistance in breast cancer
-
Elledge R, Lock-Lim S, Allred DC, Hilsenbeck S, Cordner L: p53 mutation and tamoxifen resistance in breast cancer. Clin Cancer Res 1:1203-1208, 1995
-
(1995)
Clin Cancer Res
, vol.1
, pp. 1203-1208
-
-
Elledge, R.1
Lock-Lim, S.2
Allred, D.C.3
Hilsenbeck, S.4
Cordner, L.5
-
104
-
-
0026747130
-
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of a prospective southwest oncology group study
-
Ravdin P, Green S, Door T, McGuire W, Fabian C, Pugh R, Carter R, Rivkin S, Borst J, Belt R, Metch B, Osborne CK: Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. J Clin Oncol 10(8):1284-1291, 1992
-
(1992)
J Clin Oncol
, vol.10
, Issue.8
, pp. 1284-1291
-
-
Ravdin, P.1
Green, S.2
Door, T.3
McGuire, W.4
Fabian, C.5
Pugh, R.6
Carter, R.7
Rivkin, S.8
Borst, J.9
Belt, R.10
Metch, B.11
Osborne, C.K.12
-
105
-
-
0026523778
-
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line
-
Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J: Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci 89:4495-4499, 1992
-
(1992)
Proc Natl Acad Sci
, vol.89
, pp. 4495-4499
-
-
Shaw, P.1
Bovey, R.2
Tardy, S.3
Sahli, R.4
Sordat, B.5
Costa, J.6
-
106
-
-
0027818396
-
A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis
-
Fujiwara T, Grimm E, Mukhopadhyay T, Cai D, Owen-Schaub L, Roth J: A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res 53:4129-4133, 1993
-
(1993)
Cancer Res
, vol.53
, pp. 4129-4133
-
-
Fujiwara, T.1
Grimm, E.2
Mukhopadhyay, T.3
Cai, D.4
Owen-Schaub, L.5
Roth, J.6
-
107
-
-
0028231586
-
Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene
-
Fujiwara T, Grimm E, Mukhopadhyay T, Owen-Schaub L, Roth J: Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54:2287-2291, 1994
-
(1994)
Cancer Res
, vol.54
, pp. 2287-2291
-
-
Fujiwara, T.1
Grimm, E.2
Mukhopadhyay, T.3
Owen-Schaub, L.4
Roth, J.5
-
108
-
-
0027283604
-
Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents
-
Lotern J, Sachs L: Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 82(4):1092-1096, 1993
-
(1993)
Blood
, vol.82
, Issue.4
, pp. 1092-1096
-
-
Lotern, J.1
Sachs, L.2
-
109
-
-
0027451668
-
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
-
Lowe S, Ruley H, Jacks T, Housman D: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967, 1993
-
(1993)
Cell
, vol.74
, pp. 957-967
-
-
Lowe, S.1
Ruley, H.2
Jacks, T.3
Housman, D.4
-
110
-
-
0027944206
-
p53 status and the efficacy of cancer therapy in vivo
-
Lowe S, Bodis S, McClatchey A, Remington L, Ruley H, Fisher D, Housman, D, Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810, 1994
-
(1994)
Science
, vol.266
, pp. 807-810
-
-
Lowe, S.1
Bodis, S.2
McClatchey, A.3
Remington, L.4
Ruley, H.5
Fisher, D.6
Housman, D.7
Jacks, T.8
-
111
-
-
0024556926
-
Efficacy of adjuvant chemotherapy in high risk node-negative breast cancer. An intergroup study
-
Mansour E, Gray R, Shatila A: Efficacy of adjuvant chemotherapy in high risk node-negative breast cancer. An intergroup study. N Engl J Med 320:485-490, 1989
-
(1989)
N Engl J Med
, vol.320
, pp. 485-490
-
-
Mansour, E.1
Gray, R.2
Shatila, A.3
-
112
-
-
0027078647
-
A functional screen for germ line p53 mutations based on transcriptional activation
-
Frebour T, Barbier N, Kassel J, Ng Y-S, Romero P, Friend S: A functional screen for germ line p53 mutations based on transcriptional activation. Cancer Res 52:6976-6978, 1992
-
(1992)
Cancer Res
, vol.52
, pp. 6976-6978
-
-
Frebour, T.1
Barbier, N.2
Kassel, J.3
Ng, Y.-S.4
Romero, P.5
Friend, S.6
-
113
-
-
0028674216
-
Overcoming complexities in genetic screening for cancer susceptibility
-
Friend S, Iggo R, Ishioka C, Fitzgerald M, Hoover I, O'Neill E, Frebourg T: Overcoming complexities in genetic screening for cancer susceptibility. Cold Spring Harbor Symposia on Quantitative Biology 59:673-676, 1994
-
(1994)
Cold Spring Harbor Symposia on Quantitative Biology
, vol.59
, pp. 673-676
-
-
Friend, S.1
Iggo, R.2
Ishioka, C.3
Fitzgerald, M.4
Hoover, I.5
O'Neill, E.6
Frebourg, T.7
-
114
-
-
0031574611
-
Molecular fish on chips
-
Goffeau A: Molecular fish on chips. Nature 385:202-203, 1997
-
(1997)
Nature
, vol.385
, pp. 202-203
-
-
Goffeau, A.1
-
116
-
-
0027717617
-
p21 is a universal inhibitor of cyclin kinases
-
Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704, 1993
-
(1993)
Nature
, vol.366
, pp. 701-704
-
-
Xiong, Y.1
Hannon, G.2
Zhang, H.3
Casso, D.4
Kobayashi, R.5
Beach, D.6
-
117
-
-
0027440552
-
Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes
-
Zhang H, Ziong Y, Beach D: Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4:897-906, 1993
-
(1993)
Mol Biol Cell
, vol.4
, pp. 897-906
-
-
Zhang, H.1
Ziong, Y.2
Beach, D.3
-
118
-
-
0030871776
-
p53-dependent p21 induction following γ-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line
-
Isaacs J, Chiao C, Merrick B, Selkirk J, Barrett J, Weissman B: p53-dependent p21 induction following γ-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line. Cancer Res 57:2986-2992, 1997
-
(1997)
Cancer Res
, vol.57
, pp. 2986-2992
-
-
Isaacs, J.1
Chiao, C.2
Merrick, B.3
Selkirk, J.4
Barrett, J.5
Weissman, B.6
-
119
-
-
0029670422
-
WAF1/CIP1 expression by p53-independent pathways
-
WAF1/CIP1 expression by p53-independent pathways. Oncogene 12:1557-1564, 1996
-
(1996)
Oncogene
, vol.12
, pp. 1557-1564
-
-
Zeng, Y.X.1
El-Deiry, W.S.2
-
121
-
-
0030895754
-
WAF1/CIP1 protein expression in human breast tumors
-
Diab S, Yu Y, Hilsenbeck S, Allred D, Elledge R: WAF1/CIP1 protein expression in human breast tumors. Breast Cancer Res Treat 43:99-103, 1997
-
(1997)
Breast Cancer Res Treat
, vol.43
, pp. 99-103
-
-
Diab, S.1
Yu, Y.2
Hilsenbeck, S.3
Allred, D.4
Elledge, R.5
-
122
-
-
0030223056
-
WAF1 and p53 expression in breast carcinoma: An immunohistochemical study in 261 patients with long-term follow-up
-
WAF1 and p53 expression in breast carcinoma: An immunohistochemical study in 261 patients with long-term follow-up. Clin Cancer Res 2:1591-1599, 1996
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1591-1599
-
-
Caffo, O.1
Doglioni, C.2
Veronese, S.3
Bonzanini, M.4
Marchetti, A.5
Buttitta, F.6
Fina, P.7
Leek, R.8
Morelli, L.9
Dalla Palma, P.10
Harris, A.11
Barbareschi, M.12
-
123
-
-
0000810277
-
The expression of Waf-1 in node-negative infiltrating ductal breast carcinoma
-
Johnson E, Davidson A, Hostetter R, Cook L, Thomas E, Quinlan D: The expression of Waf-1 in node-negative infiltrating ductal breast carcinoma. Proc Am Assoc Cancer Res 37:3905, 1996
-
(1996)
Proc Am Assoc Cancer Res
, vol.37
, pp. 3905
-
-
Johnson, E.1
Davidson, A.2
Hostetter, R.3
Cook, L.4
Thomas, E.5
Quinlan, D.6
-
124
-
-
0030814105
-
Absence of p21 expression is associated with abnormal p53 in human breast carcinomas
-
Ellis P, Lonning P, Borresen-Dale A, Aas T, Geisler S, Akslen L, Slater I, Smith I, Dowsett M: Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. Br J Cancer 76:480-485, 1997
-
(1997)
Br J Cancer
, vol.76
, pp. 480-485
-
-
Ellis, P.1
Lonning, P.2
Borresen-Dale, A.3
Aas, T.4
Geisler, S.5
Akslen, L.6
Slater, I.7
Smith, I.8
Dowsett, M.9
-
125
-
-
0030667191
-
p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis
-
Jiang M, Shao Z, Wu J, Lu J, Yu L, Yuan J, Han Q, Shen Z, Fontana J: p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis. Int J Cancer (Pred. Oncol.) 74:529-534, 1997
-
(1997)
Int J Cancer (Pred. Oncol.)
, vol.74
, pp. 529-534
-
-
Jiang, M.1
Shao, Z.2
Wu, J.3
Lu, J.4
Yu, L.5
Yuan, J.6
Han, Q.7
Shen, Z.8
Fontana, J.9
|